AIXC logo

AIXC AIxCrypto Holdings, Inc.

NASDAQ Capital Market · Software - Infrastructure · Technology

$1.01
-0.65 (-39.16%)

AIxCrypto Holdings, Inc. is a clinical-stage biopharmaceutical company committed to discovering and developing innovative treatments for both adult and pediatric oncology. Its leading investigational therapeutic, QN-302, is a small molecule G-quadruplexes (G4)-selective transcription inhibitor currently progressing through Phase I clinical trials for pancreatic cancer and a range of other solid tu…

Market Cap: $20.44Mwww.aixcrypto.ai

Price

$0.82-19.41%
$0.65$0.77$0.90$1.02
Jul 9Aug 7

Social Signal Score

62
5d
—
30d
80
1 mentions
+0.0%
60d
53
8 mentions
+0.0%
90d
53
8 mentions
-21.7%
news: 8

Revenue

$0.00
$0.00$633.2K$1.27M$1.90M
Sep 2017Jun 2026

Analyst Estimates

FY2025
$-35.50
$-35.50–$-35.50
1 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Jiawei Wang
Sector
Technology
Industry
Software - Infrastructure
Employees
10
Beta
0.57
Country
US
Piotroski score
2 / 9 (Weak)
Altman Z-score
-29.85
www.aixcrypto.ai